Parfezin en es it fr

Parfezin Brand names, Parfezin Analogs

Parfezin Brand Names Mixture

  • No information avaliable

Parfezin Chemical_Formula

C19H24N2S

Parfezin RX_link

No information avaliable

Parfezin fda sheet

Parfezin msds (material safety sheet)

Parfezin Synthesis Reference

No information avaliable

Parfezin Molecular Weight

312.473 g/mol

Parfezin Melting Point

64.5 oC

Parfezin H2O Solubility

0.693 mg/L

Parfezin State

Solid

Parfezin LogP

5.772

Parfezin Dosage Forms

Tablet (10 mg); Tablet (scored, 50 mg)

Parfezin Indication

For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.

Parfezin Pharmacology

Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.

Parfezin Absorption

Well-absorbed from the gastrointestinal tract.

Parfezin side effects and Toxicity

Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.

Parfezin Patient Information

Parfezin Organisms Affected

Humans and other mammals